Announcing Neuralink’s Patient Registry
December 17, 2022
Over the last few years, we have worked with patient advocacy groups and a consumer advisory board consisting of individuals with spinal cord injury and their caregivers to guide product development and community engagement.
As an expansion of these efforts, we’ve launched a Patient Registry to learn more about individuals who want to contribute to this initiative and who may be interested in enrolling in future Neuralink clinical trials, when they become available.
November 30, 2022
The first episode of our Refinement Series will look at how we evaluate the well-being of an animal as it pertains to housing, food, and water - the key elements of husbandry. We share examples of how we identify gaps in our program and how we tackle those with the help and support of our engineers and animal care teams.
Championing the 3 Rs
November 20, 2022
At Neuralink, we are committed to championing the “3 Rs” of research:
In this blog post, we describe the 3 Rs and introduce our upcoming multi-part series highlighting the challenges we encounter in animal medical research. We discuss how we think about solutions to these problems using the framework of the 3 Rs. We hope you will take this opportunity to learn alongside us as we dive into the complex world of ensuring animal well-being in a research setting.
Neuralink’s Commitment to Animal Welfare
February 14, 2022
Animals at Neuralink are respected and honored by our team. Without proper context, information from medical records and study data can be misleading. In this blog post, we want to provide an accurate statement of Neuralink’s commitment to animal welfare.
Series C Funding Round Announcement
July 29, 2021
Neuralink Corp is pleased to announce our Series C funding round of $205 million, led by Vy Capital, with participation from Google Ventures, DFJ Growth, Valor Equity Partners, Craft Ventures, Founders Fund, and Gigafund.
Pager Plays MindPong
April 18, 2021
Neuralink is developing a fully-implanted, wireless, high-channel count, brain-computer interface (BCI) with the goal of enabling people with paralysis to directly use their neural activity to operate computers and mobile devices with speed and ease.